Jacques-Olivier Bay

8PUBLICATIONS
57CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 21, 2026
Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

|Apr 16, 2026
Impact of stem cell source in HLA-matched hematopoietic stem cell transplant for acute lymphoblastic leukemia in first complete remission: a study from the GRAALL and the SFGM-TC.

|Sep 15, 2025
Thiotepa-busulfan-fludarabine compared to clofarabine-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with myeloid malignancies: a retrospective study from the SFGM-TC.

Maxime Jullien, Eolia Brissot, Etienne Daguindau

|Jun 19, 2025
Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML.

Guillaume Dachy, Myriam Labopin, Gérard Socié

|Apr 25, 2025
Author Correction: T cell malignancies after CAR T cell therapy in the DESCAR-T registry.

Remy Dulery, Vincent Guiraud, Sylvain Choquet

|Apr 03, 2025
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study.

Guillaume Cartron, Roch Houot, Yassine Al Tabaa

Pageof 2

Frequent Collaborators

4 joint publications

Edouard Forcade

3 joint publications

Hélène Labussiere-Wallet

3 joint publications

Nicolas Boissel

3 joint publications

Catherine Thieblemont